Nektar Therapeutics Charts a Course Forward: Q2 2026 Sees Strategic Investment Amidst Financial Shifts
Elicio Therapeutics Marks Significant Financial Turnaround and Pivotal Clinical Advances in Latest Quarter
Tesla Stock Climbs 3% Ahead of Q2 2026 Results as Analysts Clash Over Margins, Capex and Robotaxi Credibility
Wintrust Financial Continues Its Stellar Run, Logging Sixth Consecutive Quarter of Record Earnings in Q2 2026